Actionable news
All posts from Actionable news
Actionable news in GILD: Gilead Sciences, Inc.,

Gilead Sciences (GILD) Stock Retreats Ahead of Q1 Results Despite Credit Suisse's Optimism

NEW YORK (TheStreet) -- Gilead Sciences (GILD - Get Report) shares are slumping 1.12% to $99.59 on Thursday morning ahead of the company's 2016 first quarter results set to be released after today's market close.

Year-over-year, profit and revenue are projected to increase.

For the latest period, Wall Street is looking for earnings of $3.14 a share on revenue of $8.11 billion.

A year ago, the company earned $2.94 a share on revenue of $7.59 billion.